CoChat

LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy

Open access
Li, Gaopeng, Kryczek, Ilona, Nam, Jutaek, Li, Xiong, Li, Shasha, Li, Jing, Wei, Shuang, Grove, Sara, Vatan, Linda, Zhou, Jiajia, Du, Wan, Lin, Heng, Wang, Ton, Subramanian, Chitra, Moon, James J., Cieslik, Marcin, Cohen, Mark, Zou, Weiping · 2021 · Nature Cell Biology
Cited by 197

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Major histocompatibility complex-I (MHC-I) presents tumour antigens to CD8+ T cells and triggers anti-tumour immunity. Humans may have 30,000–60,000 long noncoding RNAs (lncRNAs). However, it remains poorly understood whether lncRNAs affect tumour immunity. Here, we identify a lncRNA, lncRNA inducing MHC-I and immunogenicity of tumour (LIMIT), in humans and mice. We found that IFNγ stimulated LIMIT, LIMIT cis-activated the guanylate-binding protein (GBP) gene cluster and GBPs disrupted the association between HSP90 and heat shock factor-1 (HSF1), thereby resulting in HSF1 activation and transcription of MHC-I machinery, but not PD-L1. RNA-guided CRISPR activation of LIMIT boosted GBPs and MHC-I, and potentiated tumour immunogenicity and checkpoint therapy. Silencing LIMIT, GBPs and/or HSF1 diminished MHC-I, impaired antitumour immunity and blunted immunotherapy efficacy. Clinically, LIMIT, GBP- and HSF1-signalling transcripts and proteins correlated with MHC-I, tumour-infiltrating T cells and checkpoint blockade response in patients with cancer. Together, we demonstrate that LIMIT is a cancer immunogenic lncRNA and the LIMIT–GBP–HSF1 axis may be targetable for cancer immunotherapy. Li et al. identify LIMIT as a lncRNA that modulates MHC-I expression through HSP90 and HSF1, thereby regulating antitumour immune response and the efficacy of immunotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41556-021-00672-3

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 197

Metadata

Authors
Li, G., Kryczek, I., Nam, J., Li, X., Li, S., Li, J., Wei, S., Grove, S., Vatan, L., Zhou, J., Du, W., Lin, H., Wang, T., Subramanian, C., Moon, J. J., Cieslik, M., Cohen, M., & Zou, W.
Venue
Nature Cell Biology
Published
2021-05
Volume
23
Issue
5
Pages
526-537
ISSN
  • 1465-7392 (ISSN-L)
  • 1476-4679
OpenAlex
W3159311544
Cited by
197
References
22
FWCI
12.88
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy. https://app.cochat.ai/papers/10.1038/s41556-021-00672-3
The paper
Li, G., Kryczek, I., Nam, J., Li, X., Li, S., Li, J., Wei, S., Grove, S., Vatan, L., Zhou, J., Du, W., Lin, H., Wang, T., Subramanian, C., Moon, J. J., Cieslik, M., Cohen, M., & Zou, W. (2021). LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy. Nature Cell Biology. https://doi.org/10.1038/s41556-021-00672-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.